{"id":2479,"date":"2017-10-31T16:15:13","date_gmt":"2017-10-31T16:15:13","guid":{"rendered":"https:\/\/lynxee.consulting\/?p=2479\/"},"modified":"2017-12-29T16:16:23","modified_gmt":"2017-12-29T16:16:23","slug":"europe-parliament-rejects-criteria-for-endocrine-disruptors","status":"publish","type":"post","link":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/","title":{"rendered":"EUROPE: Parliament rejects criteria for endocrine disruptors"},"content":{"rendered":"

On 4 October 2017, the European Parliament voted to object to the European Commission’s draft regulation setting out criteria for identifying endocrine disruptors in the area of plant protection products (PPPs).<\/span><\/p>\n

The Parliament objection regards the last paragraph of the draft regulation. The criteria proposed in the draft regulation provide for an exemption, or derogation, from the scope of the criteria for identifying EDCs, for substances that have an ‘intended endocrine mode of action’ (i.e. are deliberately designed to attack an organism’s endocrine system).<\/span><\/p>\n

The Commission regretted Parliament’s vote, reportedly stating that the derogation had been essential in getting a qualified majority among Member States to support the criteria.<\/span><\/p>\n

Now the Commission has to withdraw the draft regulation and either submit an amended version, do no further action or submit a new draft regulation. In the meantime, the interim criteria continue to apply.<\/span><\/p>\n

 <\/p>\n

To be downloaded:<\/b><\/p>\n

EU Parliament: Parliament rejects criteria for endocrine disruptors<\/span><\/a><\/p>\n

 <\/p>\n

Our previous articles: \u00a0<\/b><\/p>\n

Adoption of endocrine disruptors criteria<\/span><\/a><\/p>\n

FRANCE: List of PPPs that may contain Endocrine Disruptors (EDs)<\/span><\/a><\/p>\n

 <\/p>\n

Lynxee consulting<\/b>\u2019s team is at your disposal to answer your questions.<\/span><\/p>\n

Contact us!<\/b> https:\/\/lynxee.consulting\/en\/contact\/<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

On 4 October 2017, the European Parliament voted to object to the European Commission’s draft regulation setting out criteria for identifying endocrine disruptors in the area [\u2026]<\/span><\/p>\n","protected":false},"author":4,"featured_media":2477,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[118,181],"class_list":["post-2479","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regulation","tag-endocrine-disruptors","tag-perturbateurs-endocriniens-en"],"yoast_head":"\nEUROPE: Parliament rejects criteria for endocrine disruptors - Lynxee consulting<\/title>\n<meta name=\"description\" content=\"On 4 October 2017, the European Parliament voted to object to the European Commission's draft regulation setting out criteria for identifying endocrine\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EUROPE: Parliament rejects criteria for endocrine disruptors - Lynxee consulting\" \/>\n<meta property=\"og:description\" content=\"On 4 October 2017, the European Parliament voted to object to the European Commission's draft regulation setting out criteria for identifying endocrine\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/\" \/>\n<meta property=\"og:site_name\" content=\"Lynxee consulting\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-31T16:15:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-12-29T16:16:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/12\/notes-514998_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1258\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Vianay\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Vianay\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-parliament-rejects-criteria-for-endocrine-disruptors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-parliament-rejects-criteria-for-endocrine-disruptors\\\/\"},\"author\":{\"name\":\"\u00c9milie Vianay\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/4e2e7b2258dcb671ad7fbafa59128a5d\"},\"headline\":\"EUROPE: Parliament rejects criteria for endocrine disruptors\",\"datePublished\":\"2017-10-31T16:15:13+00:00\",\"dateModified\":\"2017-12-29T16:16:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-parliament-rejects-criteria-for-endocrine-disruptors\\\/\"},\"wordCount\":203,\"image\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-parliament-rejects-criteria-for-endocrine-disruptors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/notes-514998_1920.jpg\",\"keywords\":[\"endocrine disruptors\",\"perturbateurs endocriniens\"],\"articleSection\":[\"Regulation\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-parliament-rejects-criteria-for-endocrine-disruptors\\\/\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-parliament-rejects-criteria-for-endocrine-disruptors\\\/\",\"name\":\"EUROPE: Parliament rejects criteria for endocrine disruptors - Lynxee consulting\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-parliament-rejects-criteria-for-endocrine-disruptors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-parliament-rejects-criteria-for-endocrine-disruptors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/notes-514998_1920.jpg\",\"datePublished\":\"2017-10-31T16:15:13+00:00\",\"dateModified\":\"2017-12-29T16:16:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/4e2e7b2258dcb671ad7fbafa59128a5d\"},\"description\":\"On 4 October 2017, the European Parliament voted to object to the European Commission's draft regulation setting out criteria for identifying endocrine\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-parliament-rejects-criteria-for-endocrine-disruptors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-parliament-rejects-criteria-for-endocrine-disruptors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-parliament-rejects-criteria-for-endocrine-disruptors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/notes-514998_1920.jpg\",\"contentUrl\":\"https:\\\/\\\/lynxee.consulting\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/notes-514998_1920.jpg\",\"width\":1920,\"height\":1258},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/europe-parliament-rejects-criteria-for-endocrine-disruptors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EUROPE: Parliament rejects criteria for endocrine disruptors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#website\",\"url\":\"https:\\\/\\\/lynxee.consulting\\\/\",\"name\":\"Lynxee consulting\",\"description\":\"Innovative support for regulatory issues\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lynxee.consulting\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lynxee.consulting\\\/#\\\/schema\\\/person\\\/4e2e7b2258dcb671ad7fbafa59128a5d\",\"name\":\"\u00c9milie Vianay\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g\",\"caption\":\"\u00c9milie Vianay\"},\"sameAs\":[\"https:\\\/\\\/lynxee.consulting\"],\"url\":\"https:\\\/\\\/lynxee.consulting\\\/en\\\/author\\\/emilie\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EUROPE: Parliament rejects criteria for endocrine disruptors - Lynxee consulting","description":"On 4 October 2017, the European Parliament voted to object to the European Commission's draft regulation setting out criteria for identifying endocrine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/","og_locale":"en_US","og_type":"article","og_title":"EUROPE: Parliament rejects criteria for endocrine disruptors - Lynxee consulting","og_description":"On 4 October 2017, the European Parliament voted to object to the European Commission's draft regulation setting out criteria for identifying endocrine","og_url":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/","og_site_name":"Lynxee consulting","article_published_time":"2017-10-31T16:15:13+00:00","article_modified_time":"2017-12-29T16:16:23+00:00","og_image":[{"width":1920,"height":1258,"url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/12\/notes-514998_1920.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Vianay","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Vianay","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/#article","isPartOf":{"@id":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/"},"author":{"name":"\u00c9milie Vianay","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/4e2e7b2258dcb671ad7fbafa59128a5d"},"headline":"EUROPE: Parliament rejects criteria for endocrine disruptors","datePublished":"2017-10-31T16:15:13+00:00","dateModified":"2017-12-29T16:16:23+00:00","mainEntityOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/"},"wordCount":203,"image":{"@id":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/12\/notes-514998_1920.jpg","keywords":["endocrine disruptors","perturbateurs endocriniens"],"articleSection":["Regulation"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/","url":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/","name":"EUROPE: Parliament rejects criteria for endocrine disruptors - Lynxee consulting","isPartOf":{"@id":"https:\/\/lynxee.consulting\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/#primaryimage"},"image":{"@id":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/12\/notes-514998_1920.jpg","datePublished":"2017-10-31T16:15:13+00:00","dateModified":"2017-12-29T16:16:23+00:00","author":{"@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/4e2e7b2258dcb671ad7fbafa59128a5d"},"description":"On 4 October 2017, the European Parliament voted to object to the European Commission's draft regulation setting out criteria for identifying endocrine","breadcrumb":{"@id":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/#primaryimage","url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/12\/notes-514998_1920.jpg","contentUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/12\/notes-514998_1920.jpg","width":1920,"height":1258},{"@type":"BreadcrumbList","@id":"https:\/\/lynxee.consulting\/en\/europe-parliament-rejects-criteria-for-endocrine-disruptors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/lynxee.consulting\/en\/"},{"@type":"ListItem","position":2,"name":"EUROPE: Parliament rejects criteria for endocrine disruptors"}]},{"@type":"WebSite","@id":"https:\/\/lynxee.consulting\/#website","url":"https:\/\/lynxee.consulting\/","name":"Lynxee consulting","description":"Innovative support for regulatory issues","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lynxee.consulting\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/4e2e7b2258dcb671ad7fbafa59128a5d","name":"\u00c9milie Vianay","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1596a005fffeecedac691970c998238f8639d0641c3e3c40fcc9044ca512b7f3?s=96&d=mm&r=g","caption":"\u00c9milie Vianay"},"sameAs":["https:\/\/lynxee.consulting"],"url":"https:\/\/lynxee.consulting\/en\/author\/emilie\/"}]}},"_links":{"self":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/comments?post=2479"}],"version-history":[{"count":1,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2479\/revisions"}],"predecessor-version":[{"id":2480,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2479\/revisions\/2480"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media\/2477"}],"wp:attachment":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media?parent=2479"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/categories?post=2479"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/tags?post=2479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}